Search

U.S. Judge Rejects J&J’s $10 Billion Baby Powder Settlement

A U.S. bankruptcy judge has dismissed Johnson & Johnson’s (J&J) proposal to settle thousands of lawsuits related to its baby powder products. The proposed $10 billion settlement aimed to resolve claims that J&J’s talc-based products allegedly caused ovarian cancer among users. This ruling marks the third unsuccessful attempt by the company to navigate its legal challenges through bankruptcy proceedings.

Background on the Talcum Powder Lawsuits

Johnson & Johnson has faced an extensive array of lawsuits, with over 60,000 claimants alleging that its baby powder and other talc products contained asbestos and contributed to the development of ovarian cancer. The plaintiffs argue that J&J failed to adequately warn consumers about the potential risks associated with its talc products. Although J&J maintains that its products are safe and free from asbestos, the ongoing legal battles have raised significant concerns regarding consumer safety and corporate accountability.

Johnson & Johnson’s Bankruptcy Strategy

J&J has sought to resolve these talcum powder lawsuits through a bankruptcy strategy involving a subsidiary company. This approach aimed to consolidate talcum powder claims and facilitate a comprehensive settlement. However, previous attempts to achieve this through bankruptcy have been denied, with judges in other courts rejecting similar proposals.

The company argued that its latest proposal had garnered substantial support from affected individuals, claiming that a majority of plaintiffs were in favor of the settlement. J&J emphasized that the $10 billion offer represented a significant financial commitment to address the concerns of cancer victims.

The Judge’s Ruling Against Johnson & Johnson

U.S. Bankruptcy Judge Christopher Lopez, presiding over the case in Houston, determined that J&J did not qualify for bankruptcy protection. In his ruling, Judge Lopez stated that the proposed settlement lacked adequate backing from the women who claimed that J&J’s products caused their cancer. He highlighted that the plan extended too far by releasing claims against parties not involved in the bankruptcy process, including retailers and Kenvue, a consumer health business spun off by J&J.

Judge Lopez expressed concerns about the legitimacy of the voting process used to gauge support for the settlement, noting that many votes may have been cast without proper authority. He criticized J&J for “unnecessarily rushing” the voting process and emphasized the need for a more transparent and fair approach.

Implications for Plaintiffs with Talcum Powder Cancer Claims

The rejection of J&J’s settlement proposal opens the door for plaintiffs to pursue their claims through traditional litigation channels. Attorneys representing the plaintiffs view the ruling as a victory, allowing their clients to present their claims in court and seek justice for the alleged harm caused by J&J’s products.

J&J’s bankruptcy strategy has been condemned by critics as a “bad-faith maneuver” aimed at evading accountability. This recent ruling provides an opportunity for victims to have their voices heard and to seek the compensation they deserve.

The Future of the Talcum Powder Litigation

With the bankruptcy option off the table, the lawsuits against J&J are expected to proceed through the courts. This development could lead to lengthy legal battles as plaintiffs seek to prove their claims against the company. The potential for significant financial liability looms over J&J as the company faces mounting pressure to address the allegations against its products.

J&J’s legal team has indicated that the company intends to fight the claims vigorously. In a statement following the ruling, J&J expressed its commitment to returning to the litigation process, asserting that the claims against its talc products are meritless.

Corporate Response and Future Actions

The rejection of Johnson & Johnson’s $10 billion settlement proposal marks a pivotal moment in the ongoing legal battles surrounding its baby powder products. With the door now open for plaintiffs to pursue their claims, the implications for J&J could be far-reaching. As the company navigates the complexities of litigation, the focus on corporate accountability and consumer safety will remain at the forefront of public discourse. The outcome of these lawsuits will not only impact J&J but will also shape the landscape of consumer protection and corporate responsibility in the years to come.

Talcum Powder Lawsuit Information

Talcum powder lawsuits are alleging a link between the widely used baby powder and an increased risk of ovarian cancer and mesothelioma. Learn more by clicking on the button.
FREE
author avatar
Faith Anderson Investigative Journalist
Faith Anderson is an investigative journalist and consumer advocate with over 15 years at LeadingJustice.net. A UNC Wilmington alumna, she writes to empower individuals harmed by corporate negligence. Faith lives full-time in Puerto Rico, where her husband volunteers with the Puerto Rico Dog Fund, and she frequently travels across the U.S. to investigate claims. When not reporting, she’s surfing or spending time in nature with her rescue dogs.
Facebook
Twitter
Pinterest
LinkedIn
Reddit
WhatsApp

Related Posts

Scientists Prevail in J&J’s Defamation Lawsuit Over Talc Research

A federal judge has ruled in favor of three scientists sued by a Johnson & Johnson subsidiary over a study examining cosmetic talc exposure and mesothelioma. The subsidiary alleged that statements in the study harmed the reputation of its talc products. The court found insufficient evidence that the researchers published

Details Behind Johnson & Johnson’s $5.5 Billion Talcum Powder Settlement

In the latest update on the ongoing talcum powder cancer litigation, Johnson & Johnson (J&J) has proposed a $5.5 billion settlement to resolve nearly 80,000 lawsuits alleging that its talcum powder products, including baby powder, caused the disease. This settlement, announced on July 27, 2026, marks a potential conclusion to

California Woman Awarded $32 Million in Mesothelioma Lawsuit Against Johnson & Johnson

A Los Angeles jury recently awarded $32 million in damages to the family of a California woman who died from pleural mesothelioma, an aggressive cancer primarily linked to asbestos exposure. The court’s decision underscores the ongoing legal battles surrounding talc-based products like Johnson & Johnson’s widely used talcum powder, which

Scroll to Top